A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme

Michele Reni, Cesare Cozzarini, A. J M Ferreri, Giovanni L. Ceresoli, Laura Galli, Alessandra Bianchi, Eugenio Villa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The impact on survival of postradiation nitrosourea-containing chemotherapy (CHT) in patients with glioblastoma multiforme (GM) was analyzed retrospectively in 133 patients who completed the planned radiotherapy out of 173 observed cases. Thirty-five patients were 60 Gy, and CHT had an independent prognostic value. Our results suggest that chemotherapy improves 2-year survival rates from 12% to 28% in GM. The sequence of treatment, new drugs, and combinations should be further explored.

Original languageEnglish
Pages (from-to)510-515
Number of pages6
JournalCancer Investigation
Volume18
Issue number6
Publication statusPublished - 2000

Fingerprint

Glioblastoma
Drug Therapy
Drug Combinations
Radiotherapy
Survival Rate
Survival
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme. / Reni, Michele; Cozzarini, Cesare; Ferreri, A. J M; Ceresoli, Giovanni L.; Galli, Laura; Bianchi, Alessandra; Villa, Eugenio.

In: Cancer Investigation, Vol. 18, No. 6, 2000, p. 510-515.

Research output: Contribution to journalArticle

@article{49aecf3654314c2a80606ef1f557822e,
title = "A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme",
abstract = "The impact on survival of postradiation nitrosourea-containing chemotherapy (CHT) in patients with glioblastoma multiforme (GM) was analyzed retrospectively in 133 patients who completed the planned radiotherapy out of 173 observed cases. Thirty-five patients were 60 Gy, and CHT had an independent prognostic value. Our results suggest that chemotherapy improves 2-year survival rates from 12{\%} to 28{\%} in GM. The sequence of treatment, new drugs, and combinations should be further explored.",
author = "Michele Reni and Cesare Cozzarini and Ferreri, {A. J M} and Ceresoli, {Giovanni L.} and Laura Galli and Alessandra Bianchi and Eugenio Villa",
year = "2000",
language = "English",
volume = "18",
pages = "510--515",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme

AU - Reni, Michele

AU - Cozzarini, Cesare

AU - Ferreri, A. J M

AU - Ceresoli, Giovanni L.

AU - Galli, Laura

AU - Bianchi, Alessandra

AU - Villa, Eugenio

PY - 2000

Y1 - 2000

N2 - The impact on survival of postradiation nitrosourea-containing chemotherapy (CHT) in patients with glioblastoma multiforme (GM) was analyzed retrospectively in 133 patients who completed the planned radiotherapy out of 173 observed cases. Thirty-five patients were 60 Gy, and CHT had an independent prognostic value. Our results suggest that chemotherapy improves 2-year survival rates from 12% to 28% in GM. The sequence of treatment, new drugs, and combinations should be further explored.

AB - The impact on survival of postradiation nitrosourea-containing chemotherapy (CHT) in patients with glioblastoma multiforme (GM) was analyzed retrospectively in 133 patients who completed the planned radiotherapy out of 173 observed cases. Thirty-five patients were 60 Gy, and CHT had an independent prognostic value. Our results suggest that chemotherapy improves 2-year survival rates from 12% to 28% in GM. The sequence of treatment, new drugs, and combinations should be further explored.

UR - http://www.scopus.com/inward/record.url?scp=0033943967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033943967&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 510

EP - 515

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 6

ER -